This compound is primarily utilized in the field of pharmaceutical research and development, particularly in the synthesis of bioactive molecules and drug candidates. Its structure, featuring a benzyloxycarbonyl-protected amino group and a 2,3-dihydro-1H-inden-2-yl moiety, makes it a valuable intermediate in the preparation of chiral compounds. It is often employed in the development of peptidomimetics and small molecule inhibitors, which are crucial in targeting specific enzymes or receptors involved in various diseases. Additionally, its chiral nature allows for the exploration of stereoselective reactions, contributing to the design of more effective and selective therapeutic agents.